Exploring the interaction between sensory neurons and drug aversion can offer clues to the genetic basis of addiction.

For women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for hormone receptor (HR)-positive ...

A new review sheds light on the complex molecular mechanisms behind Angelman syndrome (AS), a rare neurogenetic disorder, and ...

CBD Life Sciences Inc. (CBDL) has entered the $2.8 billion global suppository market with the launch of its new line of ...

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Relacorilant combined with nab-paclitaxel (Abraxane) significantly improved progression-free and overall survival in patients with platinum-resistant ovarian cancer in the phase 3 ROSELLA trial, ...

Kisqali plus aromatase inhibitor improved outcomes across age and menopausal status in early hormone receptor–positive, ...

CBDL Enters the $2.8 Billion Suppository Market with a First-of-Its-Kind Product - Tapping a High-Demand, Low-Competition ...

A groundbreaking study has unveiled a promising new therapy for lymphoma using the radioactive isotope terbium-161 ...